How to check Neuralink clinical trials and the official Patient Registry
Whether you are a patient, caregiver, clinician, or researcher, checking clinical trial information requires reading official study brochures and federal registry records directly. This five-step guide walks through how to inspect Neuralink's Patient Registry and ClinicalTrials.gov entries for PRIME (NCT06429735), CONVOY, and VOICE (NCT07224256)—and how to discuss trial participation with an independent physician.
- This guide is for educational and research verification only and is never medical advice; always consult a qualified neurologist or neurosurgeon.
- Neuralink's only official intake portal is the Patient Registry at
neuralink.com/trials/plus institutional clinical sites such as Barrow Neurological Institute. - Review the official PRIME Study Brochure PDF (
neuralink.com/pdfs/PRIME-Study-Brochure.pdf) and ClinicalTrials.gov recordsNCT06429735andNCT07224256. - Legitimate clinical trials never charge enrollment fees over social media or ask patients to buy crypto tokens.
Step-by-step workflow
- Step 1 of 5
Start at neuralink.com/trials/ and read the official study brochures
Navigate directly to https://neuralink.com/trials/ and https://neuralink.com/trials/speech-restoration/. Download the official PRIME Study Brochure PDF (https://neuralink.com/pdfs/PRIME-Study-Brochure.pdf), which explains what the study tests, the approximate multi-year follow-up schedule, and general eligibility.
Verification check: Verify that the browser address bar shows neuralink.com over HTTPS before entering any personal health information.
- Step 2 of 5
Compare the three active study tracks (PRIME, CONVOY, and VOICE)
Identify which protocol matches the clinical question: PRIME evaluates N1/R1 safety and wireless computer control in quadriplegia (such as cervical spinal cord injury or ALS); CONVOY evaluates controlling an assistive robotic arm; VOICE evaluates speech decoding for severe communication impairment.
Verification check: Each study has specific age, medical-stability, and anatomical inclusion and exclusion criteria.
- Step 3 of 5
Inspect the federal registration on ClinicalTrials.gov
Open https://clinicaltrials.gov/study/NCT06429735 (The PRIME Study) and https://clinicaltrials.gov/study/NCT07224256 (The VOICE Study). Review the 'Participation Criteria', 'Contacts and Locations', and 'Study Plan' sections.
Verification check: ClinicalTrials.gov lists institutional clinical sites such as Barrow Neurological Institute in Phoenix, Arizona.
- Step 4 of 5
Understand what joining the Patient Registry entails
Submitting an application to the Neuralink Patient Registry (or an international registry in the US, Canada, UK, UAE, or global portal) does not automatically enroll a person in surgery. It initiates a pre-screening medical records review followed by formal informed-consent discussions with the study's clinical investigators.
Verification check: Participation in any clinical trial is voluntary, and participants have the right to withdraw under informed-consent protections.
- Step 5 of 5
Discuss benefits, surgical risks, and alternatives with an independent neurologist
Before making any decision about an investigational Class III neurosurgical trial, review the full informed-consent packet with an independent physician who is not affiliated with the device sponsor.
Verification check: Ask specifically about surgical risks, post-operative follow-up commitments, alternative assistive technologies, and long-term device management.
Watch Neuralink's official introduction to the clinical trials
In November 2025, Neuralink released a concise video overview explaining how its clinical trial team works with participants from registry screening through surgical recovery and home decoding:
Official November 2025 video ('An Introduction to the Neuralink Clinical Trials') outlining the PRIME, CONVOY, and VOICE clinical trial workflow.
Quick reference: official clinical trial links
| Resource | Verified destination | Purpose |
|---|---|---|
| Neuralink Clinical Trials & Registry | https://neuralink.com/trials/ | Official intake portal and study overview. |
| VOICE Speech Restoration Page | https://neuralink.com/trials/speech-restoration/ | Overview of the VOICE clinical trial. |
| PRIME Study Brochure (PDF) | https://neuralink.com/pdfs/PRIME-Study-Brochure.pdf | Participant-facing brochure detailing PRIME study stages. |
| ClinicalTrials.gov: PRIME | https://clinicaltrials.gov/study/NCT06429735 | Federal protocol record for NCT06429735. |
| ClinicalTrials.gov: VOICE | https://clinicaltrials.gov/study/NCT07224256 | Federal protocol record for NCT07224256. |
| Barrow Neurological Institute | https://www.barrowneuro.org/patient-care/take-action/find-a-clinical-trial/clinical-trial/prime-study/ | Hospital clinical site page for the PRIME Study. |
Sources checked 30 Oct 2026
Sources and official records
- [1] Neuralink: Clinical Trials and Patient Registry ↗ · Verified 30 Oct 2026
- [2] Neuralink: Speech Restoration (VOICE study overview) ↗ · Verified 30 Oct 2026
- [3] Neuralink: PRIME Study Brochure (PDF) ↗ · Verified 30 Oct 2026
- [4] ClinicalTrials.gov: The PRIME Study (NCT06429735) ↗ · Verified 30 Oct 2026
- [5] ClinicalTrials.gov: The VOICE Study for Communication Restoration (NCT07224256) ↗ · Verified 30 Oct 2026
- [6] Barrow Neurological Institute: PRIME Study Clinical Trial Information ↗ · Verified 30 Oct 2026
- [7] Neuralink YouTube (2026-04-16): From Neural Signals To Life-Changing Impact | Neuralink ↗ · Verified 30 Oct 2026
- [8] U.S. FDA: Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation ↗ · Verified 30 Oct 2026